/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Andrew P. Cope

King's College London(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

425

Papers

13.7K

Citations

60

h-index

179

i10-index

Andrew P. Cope is an academic researcher from King's College London. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & T-cell and B-cell Immunology & Systemic Lupus Erythematosus Research. The author has an h-index of 60, co-authored 362 publications.

ORCID: 0000-0001-6735-5496

Research Topics

Rheumatoid Arthritis Research and Therapies T-cell and B-cell Immunology Systemic Lupus Erythematosus Research Monoclonal and Polyclonal Antibodies Research Immune Cell Function and Interaction

Papers by this author

works

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

2012 · Annals of the Rheumatic Diseases · 448 citations

https://doi.org/10.1136/annrheumdis-2011-200990

Daniëlle M. Gerlag Karim Raza Lisa G. M. van Baarsen Elisabeth Brouwer

Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study

2020 · The Lancet Rheumatology · 171 citations

https://doi.org/10.1016/s2665-9913(20)30064-3

Philippa M. Wells Adewale Adebayo Ruth C. E. Bowyer Maxim B. Freidin

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005.

2007 · Arthritis Research & Therapy · 157 citations

https://doi.org/10.1186/ar2103

Alan Tyndall Ulrich A. Walker Andrew P. Cope Francesco Dazzi

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

2024 · The Lancet · 138 citations

https://doi.org/10.1016/s0140-6736(23)02649-1

Andrew P. Cope Marianna Jasenecova Joana C. Vasconcelos Andrew Filer

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

2019 · Trials · 100 citations

https://doi.org/10.1186/s13063-019-3403-7

Mariam Al-Laith Marianna Jasenecova Sonya Abraham Aisla Bosworth

Cell therapy for autoimmune diseases

2007 · Arthritis Research & Therapy · 88 citations

https://doi.org/10.1186/ar2128

Francesco Dazzi Jacob M. van Laar Andrew P. Cope Alan Tyndall

Research topics

topics

Rheumatoid Arthritis Research and Therapies

T-cell and B-cell Immunology

Systemic Lupus Erythematosus Research

Monoclonal and Polyclonal Antibodies Research

Immune Cell Function and Interaction

Chat about Author

Papers

Chat

Click to start Chat